Getein Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Getein Biotech has a total shareholder equity of CN¥2.8B and total debt of CN¥640.4M, which brings its debt-to-equity ratio to 22.7%. Its total assets and total liabilities are CN¥3.8B and CN¥963.6M respectively. Getein Biotech's EBIT is CN¥174.7M making its interest coverage ratio -4. It has cash and short-term investments of CN¥936.9M.
Key information
22.7%
Debt to equity ratio
CN¥640.43m
Debt
Interest coverage ratio | -4x |
Cash | CN¥936.89m |
Equity | CN¥2.82b |
Total liabilities | CN¥963.62m |
Total assets | CN¥3.79b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603387's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥911.9M).
Long Term Liabilities: 603387's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥51.7M).
Debt to Equity History and Analysis
Debt Level: 603387 has more cash than its total debt.
Reducing Debt: 603387's debt to equity ratio has increased from 2.7% to 22.7% over the past 5 years.
Debt Coverage: 603387's debt is well covered by operating cash flow (60.4%).
Interest Coverage: 603387 earns more interest than it pays, so coverage of interest payments is not a concern.